Sectors
SCNI
Scinai Immunotherapeutics Ltd.
0.25
10 x 0.24
1 x 0.28
bid
ask
+
0.00
1.79%
09:15 AM
timesize
| Ytd | -64.89% | |
| 1y | -88.64% |
0.24
day range
0.25
0.21
52 week range
3.48
| Open | 0.24 | Prev Close | 0.25 | Low | 0.24 | High | 0.25 | Mkt Cap | 323.05K |
| Vol | 20.77K | Avg Vol | 3.71M | EPS | -14.23 | P/E | -0.02 | Forward P/E | N/A |
| Beta | 2.11 | Short Ratio | 0.09 | Inst. Own | 2.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.37 | 200-d Avg | 0.77 | 1yr Est | 700.00 |
| Income Statement | |||
| Total Revenue | 489.00K | ||
| Revenues (USD) | 489.00K | ||
| Cost of Revenue | 1.61M | ||
| Gross Profit | -1.12M | ||
| Operating Expenses | 1.35M | ||
| Research and Development Expense | 628.00K | ||
| Selling, General and Administrative Expense | 721.00K | ||
| Operating Income | -2.47M | ||
| Net Income | 3.58M | ||
| Net Income Common Stock | 3.58M | ||
| Net Income Common Stock (USD) | 3.58M | ||
| Consolidated Income | 3.58M | ||
| Earning Before Interest & Taxes (EBIT) | 3.58M | ||
| Earning Before Interest & Taxes (USD) | 3.58M | ||
| Weighted Average Shares | 15.15B | ||
| Weighted Average Shares Diluted | 15.15B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.11M | ||
| Cash and Equivalents (USD) | 3.11M | ||
| Trade and Non-Trade Receivables | 150.00K | ||
| Current Assets | 3.61M | ||
| Property, Plant & Equipment Net | 13.97M | ||
| Total Assets | 17.59M | ||
| Debt Current | 354.00K | ||
| Total Debt | 3.50M | ||
| Current Liabilities | 2.69M | ||
| Debt Non-Current | 3.14M | ||
| Total Liabilities | 5.83M | ||
| Accumulated Retained Earnings (Deficit) | -122.27M | ||
| Accumulated Other Comprehensive Income | -1.74M | ||
| Shareholders Equity | 11.76M | ||
| Shareholders Equity (USD) | 11.76M | ||
| Assets Non-Current | 13.97M | ||
| Total Debt (USD) | 3.50M | ||
| Liabilities Non-Current | 3.14M | ||
| Trade and Non-Trade Payables | 2.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 453.00K | ||
| Net Cash Flow from Financing | 11.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.30M | ||
| Capital Expenditure | -3.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 2.75M | ||
| Issuance (Purchase) of Equity Shares | 11.00K | ||
| Net Cash Flow from Investing | 2.75M | ||
| Net Cash Flow from Operations | -1.46M | ||
| Share Based Compensation | 70.00K | ||